This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $23,537.50 firm fixed-price delivery order is for SKYLA 13.5 MG SYSTEMS and has an ultimate completion date of October 9, 2024.
DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. This IDC, which runs through December 31, 2025, complements the company's separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to Department of Defense (DoD) sites, solidifying DMS Pharmaceutical Group's position as a crucial supplier in the federal pharmaceutical supply chain.
Generated 12/18/24, 9:02 AM